Article info

Download PDFPDF

Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study

Authors

  1. Correspondence to Professor Alessandro Lambiase, University Sapienza of Rome, Rome 00185, Italy; alessandro.lambiase{at}uniroma1.it
View Full Text

Citation

Sacchetti M, Lambiase A, Schmidl D, et al
Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study

Publication history

  • Received April 24, 2018
  • Revised February 19, 2019
  • Accepted March 9, 2019
  • First published April 3, 2019.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.